Holding Mycophenolate Helps Immune Response to COVID Vaccination

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Withholding mycophenolate around the time of vaccination against SARS-CoV-2 proved safe and augmented the humoral response to vaccination among a group of patients at one center who were taking the immunosuppressive drug for a variety of rheumatic and musculoskeletal diseases (RMDs).

Previous studies have shown that use of mycophenolate attenuates the humoral response to SARS-CoV-2 vaccination, and the most up-to-date recommendations from the American College of Rheumatology on SARS-CoV-2 vaccination in patients with RMDs advise that mycophenolate should be withheld for a week after receiving the vaccine.

To understand better how withholding mycophenolate would affect immune response to SARS-CoV-2 vaccination, rheumatology fellow Caoilfhionn M. Connolly, MD, and coauthors at Johns Hopkins University, Baltimore, described in their report – published online Sept. 23, 2021, in Annals of the Rheumatic Diseases – how they compared the immune responses to vaccination in 24 patients who withheld mycophenolate and 171 patients who did not stop taking it. All but 1 of the 24 patients who withheld mycophenolate were female, with a median age of 51 years, and they had mostly systemic lupus erythematosus (6 patients), myositis (5), scleroderma (4), or overlap connective tissue disease (4). Three patients received the Janssen/Johnson & Johnson vaccine; all others received either the two-dose Moderna or Pfizer/BioNTech mRNA series.

At a median of 32 days after vaccination, all but two of the patients (92%) who withheld mycophenolate had detectable antibodies against the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, compared with 65% of those who continued the drug (P=.01). This calculated to patients who withheld the drug as having nearly sixfold higher odds for a positive antibody response (odds ratio, 5.8; 95% CI, 1.3-25.5; P=.02). The association remained statistically significant in an logistic regression analysis that was adjusted for age, sex, race, vaccine type, and use of rituximab and glucocorticoids.

The withholding group also had significantly higher median anti-RBD immunoglobulin titers than did the group that continued therapy (125 vs. 7 U/L; P=.004).

Two patients who reported a flare of their underlying disease during the perivaccination period were treated with topical and oral glucocorticoids.

The patients who withdrew mycophenolate had taken it with twice daily dosing at a median total daily dose of 2,000 mg. They ended up withholding a median of 20 doses around the time of vaccination, with 54% withholding before, 38% both before and after, and 8% only after vaccination.

The researchers said that the conclusions that can be drawn from the study were limited by its small sample size, which “did not allow for evaluation of optimal duration of withholding therapy,” and also its “nonrandomized design, lack of data on cellular response, and limited information on dosing of other immunosuppressive agents.”

Three of the authors disclosed receiving consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, and Thermo Fisher Scientific. A fourth author has received consulting fees from Janssen, Boehringer Ingelheim, Mallinckrodt, EMD Serono, Allogene, and ArgenX.

This article originally appeared on MDedge.com, part of the Medscape Professional Network.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Study: Black/African American individuals have an increased risk for severe insulin-deficient diabetes thumbnail

Study: Black/African American individuals have an increased risk for severe insulin-deficient diabetes

Credit: Unsplash/CC0 Public Domain While diabetes patients are categorized into two groups, either type 1 or type 2, no two patients are the same. The simple categorization often does not portray the disease and its many presentations, especially within different populations. For this reason, diabetes researchers and clinicians have emphasized the importance of increasing the
Read More
Interns warn: "Hospitals must prepare for mass resignation" thumbnail

Interns warn: “Hospitals must prepare for mass resignation”

יותר מ-1,600 מתמחים, סטאז'רים וסטודנטים חתמו על כוונתם להתפטר במידה שיאושר מתווה קיצור תורנויות שחורג מ-18 שעות עבודה רצופות (16+2), זאת במסגרת עצומת התפטרות המונית שיזם ארגון המתמחים מרשם. המתמחים מוחים על מתווה התורנויות שמקודם בימים אלה על ידי גורמים במערכת הבריאות ובמערכת הפוליטית, המתייחס לתורנויות של 21/ 22 שעות רצופות ומתנגדים לו בכל תוקף. ד"ר…
Read More
Why Residents Are Joining Unions in Droves thumbnail

Why Residents Are Joining Unions in Droves

Please enable cookies. Error 1005 Ray ID: 8d4b29495d256ebf • 2024-10-18 20:08:36 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 8d4b29495d256ebf • Your IP: 185.124.111.116 •
Read More
수원시 고위 공무원들 1박2일 여행 갔다 미접종자 1명 포함 4명 확진 판정 thumbnail

수원시 고위 공무원들 1박2일 여행 갔다 미접종자 1명 포함 4명 확진 판정

미접종자와 함께 음식점 등 찾지 않았다며 방역수칙 위반 의혹은 부인 세계일보 자료사진 경기 수원시 소속 고위직 공무원들이 사적 모임을 가졌다가 대거 확진 판정을 받았다. 26일 수원시 등에 따르면 지난 22일 시청 국장(서기관·4급)·과장(사무관·5급) 등 6명은 충남 홍성과 예산 등지에서 1박 2일 일정으로 스크린 골프와 시내 투어, 농가 체험 등을 즐겼다. A국장은 일정을 진행하다 몸이 좋지 않아 먼저 집에…
Read More
Index Of News
Total
0
Share